Pharmaceutical Distribution Process Requires for Transparency Among All Constituents

A number of instances surrounding negative sales practices by the pharmaceutical manufactures, such as irregular price discounts, premiums and rebates, is putting all the related industry constituents to keenly focus on the possible outcomes decided by the government, as the year approaches to its end.

Especially, a possible criminal proceeding is not without consideration, where it has been...